BREAKING CDC: Time to resume Johnson & Johnson vaccine
By LAURAN NEERGAARD and MIKE STOBBE Associated Press A U.S. health panel says it's time to resume use of Johnson & Johnson's COVID-19 vaccine, despite a very rare risk of blood clots. Out of nearly 8 million people vaccinated before the U.S. suspended J&J's shot, health officials uncovered ...